StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — Muthu Selvaraj, Sharekhan

BUYAarti Pharmalabs Limited
Aarti Pharmalabs share price target & all analyst calls

byMuthu Selvaraj, SharekhanHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via CNBC Awaaz.

Entry₹864Inferred
Target₹950
Total upside +9.95% (call closed)
Stop loss₹810-6.25% risk
Exit₹95023 Sept 2026, 10:05 am
Target hit+9.95%0.00%upside left
Follow Muthu Selvaraj for new calls(16% target hit, 38 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Sept 2026
0 supporting2 neutral0 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (2)

Aarti Pharmalabs Insider Ups Holding During Year

NewsGoogle News·16 Sept · 1w ago

(opens in new tab)

Dividend stocks alert, record date: Last chance to buy - Blue Dart, Karnataka Bank, Aarti Pharma, ITDC | Full list

NewsGoogle News·14 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Pharmalabs

All analyst calls on Aarti Pharmalabs

More from Muthu Selvaraj, Sharekhan

Every call and its outcome